nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Cranial nerve paralysis—Vincristine—sarcoma	0.15	0.15	CcSEcCtD
Nalidixic Acid—Metabolic acidosis—Etoposide—sarcoma	0.0355	0.0355	CcSEcCtD
Nalidixic Acid—Optic neuritis—Etoposide—sarcoma	0.0228	0.0228	CcSEcCtD
Nalidixic Acid—Swelling—Mitoxantrone—sarcoma	0.0139	0.0139	CcSEcCtD
Nalidixic Acid—Optic neuritis—Epirubicin—sarcoma	0.0128	0.0128	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.0126	0.0126	CcSEcCtD
Nalidixic Acid—Optic neuritis—Doxorubicin—sarcoma	0.0118	0.0118	CcSEcCtD
Nalidixic Acid—Swelling—Etoposide—sarcoma	0.0115	0.0115	CcSEcCtD
Nalidixic Acid—Blister—Epirubicin—sarcoma	0.0109	0.0109	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.0107	0.0107	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Etoposide—sarcoma	0.0105	0.0105	CcSEcCtD
Nalidixic Acid—Blister—Doxorubicin—sarcoma	0.0101	0.0101	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Vincristine—sarcoma	0.00991	0.00991	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Vincristine—sarcoma	0.00949	0.00949	CcSEcCtD
Nalidixic Acid—Drowsiness—Mitoxantrone—sarcoma	0.00943	0.00943	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Dactinomycin—sarcoma	0.0092	0.0092	CcSEcCtD
Nalidixic Acid—Erythema—Thiotepa—sarcoma	0.00853	0.00853	CcSEcCtD
Nalidixic Acid—Erythema—Dactinomycin—sarcoma	0.00847	0.00847	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00777	0.00777	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Etoposide—sarcoma	0.00769	0.00769	CcSEcCtD
Nalidixic Acid—Leukopenia—Thiotepa—sarcoma	0.00764	0.00764	CcSEcCtD
Nalidixic Acid—Leukopenia—Dactinomycin—sarcoma	0.00758	0.00758	CcSEcCtD
Nalidixic Acid—Convulsion—Thiotepa—sarcoma	0.00739	0.00739	CcSEcCtD
Nalidixic Acid—Erythema—Mitoxantrone—sarcoma	0.00737	0.00737	CcSEcCtD
Nalidixic Acid—Arthralgia—Thiotepa—sarcoma	0.00726	0.00726	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Thiotepa—sarcoma	0.00682	0.00682	CcSEcCtD
Nalidixic Acid—Vertigo—Vincristine—sarcoma	0.0068	0.0068	CcSEcCtD
Nalidixic Acid—Leukopenia—Vincristine—sarcoma	0.00677	0.00677	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Dactinomycin—sarcoma	0.00677	0.00677	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Etoposide—sarcoma	0.00666	0.00666	CcSEcCtD
Nalidixic Acid—Leukopenia—Mitoxantrone—sarcoma	0.00659	0.00659	CcSEcCtD
Nalidixic Acid—Convulsion—Vincristine—sarcoma	0.00655	0.00655	CcSEcCtD
Nalidixic Acid—Convulsion—Mitoxantrone—sarcoma	0.00638	0.00638	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00634	0.00634	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.0063	0.0063	CcSEcCtD
Nalidixic Acid—Arthralgia—Mitoxantrone—sarcoma	0.00627	0.00627	CcSEcCtD
Nalidixic Acid—Paraesthesia—Thiotepa—sarcoma	0.00625	0.00625	CcSEcCtD
Nalidixic Acid—Somnolence—Thiotepa—sarcoma	0.00619	0.00619	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Vincristine—sarcoma	0.00617	0.00617	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vincristine—sarcoma	0.00605	0.00605	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Mitoxantrone—sarcoma	0.00601	0.00601	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Epirubicin—sarcoma	0.00597	0.00597	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Epirubicin—sarcoma	0.00589	0.00589	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Mitoxantrone—sarcoma	0.00589	0.00589	CcSEcCtD
Nalidixic Acid—Diplopia—Epirubicin—sarcoma	0.0057	0.0057	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Thiotepa—sarcoma	0.00569	0.00569	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Dactinomycin—sarcoma	0.00565	0.00565	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Vincristine—sarcoma	0.00563	0.00563	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vincristine—sarcoma	0.00554	0.00554	CcSEcCtD
Nalidixic Acid—Urticaria—Thiotepa—sarcoma	0.00553	0.00553	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—sarcoma	0.00552	0.00552	CcSEcCtD
Nalidixic Acid—Vertigo—Etoposide—sarcoma	0.00551	0.00551	CcSEcCtD
Nalidixic Acid—Abdominal pain—Thiotepa—sarcoma	0.0055	0.0055	CcSEcCtD
Nalidixic Acid—Leukopenia—Etoposide—sarcoma	0.00549	0.00549	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00548	0.00548	CcSEcCtD
Nalidixic Acid—Abdominal pain—Dactinomycin—sarcoma	0.00546	0.00546	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00545	0.00545	CcSEcCtD
Nalidixic Acid—Paraesthesia—Mitoxantrone—sarcoma	0.0054	0.0054	CcSEcCtD
Nalidixic Acid—Somnolence—Mitoxantrone—sarcoma	0.00535	0.00535	CcSEcCtD
Nalidixic Acid—Convulsion—Etoposide—sarcoma	0.00531	0.00531	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—sarcoma	0.00528	0.00528	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vincristine—sarcoma	0.00505	0.00505	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Etoposide—sarcoma	0.005	0.005	CcSEcCtD
Nalidixic Acid—Asthenia—Thiotepa—sarcoma	0.005	0.005	CcSEcCtD
Nalidixic Acid—Asthenia—Dactinomycin—sarcoma	0.00496	0.00496	CcSEcCtD
Nalidixic Acid—Pruritus—Thiotepa—sarcoma	0.00493	0.00493	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00492	0.00492	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Etoposide—sarcoma	0.0049	0.0049	CcSEcCtD
Nalidixic Acid—Eosinophilia—Epirubicin—sarcoma	0.00488	0.00488	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vincristine—sarcoma	0.00488	0.00488	CcSEcCtD
Nalidixic Acid—Urticaria—Mitoxantrone—sarcoma	0.00478	0.00478	CcSEcCtD
Nalidixic Acid—Diarrhoea—Thiotepa—sarcoma	0.00476	0.00476	CcSEcCtD
Nalidixic Acid—Abdominal pain—Mitoxantrone—sarcoma	0.00475	0.00475	CcSEcCtD
Nalidixic Acid—Diarrhoea—Dactinomycin—sarcoma	0.00473	0.00473	CcSEcCtD
Nalidixic Acid—Dizziness—Thiotepa—sarcoma	0.0046	0.0046	CcSEcCtD
Nalidixic Acid—Eosinophilia—Doxorubicin—sarcoma	0.00452	0.00452	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Epirubicin—sarcoma	0.0045	0.0045	CcSEcCtD
Nalidixic Acid—Paraesthesia—Etoposide—sarcoma	0.00449	0.00449	CcSEcCtD
Nalidixic Acid—Somnolence—Etoposide—sarcoma	0.00445	0.00445	CcSEcCtD
Nalidixic Acid—Asthenia—Vincristine—sarcoma	0.00443	0.00443	CcSEcCtD
Nalidixic Acid—Vomiting—Thiotepa—sarcoma	0.00443	0.00443	CcSEcCtD
Nalidixic Acid—Drowsiness—Epirubicin—sarcoma	0.0044	0.0044	CcSEcCtD
Nalidixic Acid—Vomiting—Dactinomycin—sarcoma	0.00439	0.00439	CcSEcCtD
Nalidixic Acid—Rash—Thiotepa—sarcoma	0.00439	0.00439	CcSEcCtD
Nalidixic Acid—Dermatitis—Thiotepa—sarcoma	0.00439	0.00439	CcSEcCtD
Nalidixic Acid—Headache—Thiotepa—sarcoma	0.00436	0.00436	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00436	0.00436	CcSEcCtD
Nalidixic Acid—Rash—Dactinomycin—sarcoma	0.00436	0.00436	CcSEcCtD
Nalidixic Acid—Asthenia—Mitoxantrone—sarcoma	0.00431	0.00431	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Epirubicin—sarcoma	0.00431	0.00431	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vincristine—sarcoma	0.00422	0.00422	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—sarcoma	0.00416	0.00416	CcSEcCtD
Nalidixic Acid—Nausea—Thiotepa—sarcoma	0.00414	0.00414	CcSEcCtD
Nalidixic Acid—Diarrhoea—Mitoxantrone—sarcoma	0.00411	0.00411	CcSEcCtD
Nalidixic Acid—Nausea—Dactinomycin—sarcoma	0.0041	0.0041	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Etoposide—sarcoma	0.00409	0.00409	CcSEcCtD
Nalidixic Acid—Dizziness—Vincristine—sarcoma	0.00408	0.00408	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—sarcoma	0.00407	0.00407	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00403	0.00403	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—sarcoma	0.00399	0.00399	CcSEcCtD
Nalidixic Acid—Urticaria—Etoposide—sarcoma	0.00397	0.00397	CcSEcCtD
Nalidixic Acid—Abdominal pain—Etoposide—sarcoma	0.00395	0.00395	CcSEcCtD
Nalidixic Acid—Vomiting—Vincristine—sarcoma	0.00393	0.00393	CcSEcCtD
Nalidixic Acid—Rash—Vincristine—sarcoma	0.00389	0.00389	CcSEcCtD
Nalidixic Acid—Dermatitis—Vincristine—sarcoma	0.00389	0.00389	CcSEcCtD
Nalidixic Acid—Headache—Vincristine—sarcoma	0.00387	0.00387	CcSEcCtD
Nalidixic Acid—Vomiting—Mitoxantrone—sarcoma	0.00382	0.00382	CcSEcCtD
Nalidixic Acid—Visual impairment—Epirubicin—sarcoma	0.0038	0.0038	CcSEcCtD
Nalidixic Acid—Rash—Mitoxantrone—sarcoma	0.00379	0.00379	CcSEcCtD
Nalidixic Acid—Dermatitis—Mitoxantrone—sarcoma	0.00379	0.00379	CcSEcCtD
Nalidixic Acid—Headache—Mitoxantrone—sarcoma	0.00377	0.00377	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Epirubicin—sarcoma	0.00373	0.00373	CcSEcCtD
Nalidixic Acid—Nausea—Vincristine—sarcoma	0.00367	0.00367	CcSEcCtD
Nalidixic Acid—Asthenia—Etoposide—sarcoma	0.00359	0.00359	CcSEcCtD
Nalidixic Acid—Nausea—Mitoxantrone—sarcoma	0.00357	0.00357	CcSEcCtD
Nalidixic Acid—Pruritus—Etoposide—sarcoma	0.00354	0.00354	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—sarcoma	0.00352	0.00352	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Doxorubicin—sarcoma	0.00345	0.00345	CcSEcCtD
Nalidixic Acid—Erythema—Epirubicin—sarcoma	0.00344	0.00344	CcSEcCtD
Nalidixic Acid—Diarrhoea—Etoposide—sarcoma	0.00342	0.00342	CcSEcCtD
Nalidixic Acid—Dizziness—Etoposide—sarcoma	0.00331	0.00331	CcSEcCtD
Nalidixic Acid—Vomiting—Etoposide—sarcoma	0.00318	0.00318	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—sarcoma	0.00318	0.00318	CcSEcCtD
Nalidixic Acid—Rash—Etoposide—sarcoma	0.00315	0.00315	CcSEcCtD
Nalidixic Acid—Dermatitis—Etoposide—sarcoma	0.00315	0.00315	CcSEcCtD
Nalidixic Acid—Headache—Etoposide—sarcoma	0.00313	0.00313	CcSEcCtD
Nalidixic Acid—Vertigo—Epirubicin—sarcoma	0.00309	0.00309	CcSEcCtD
Nalidixic Acid—Leukopenia—Epirubicin—sarcoma	0.00307	0.00307	CcSEcCtD
Nalidixic Acid—Convulsion—Epirubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Nalidixic Acid—Nausea—Etoposide—sarcoma	0.00297	0.00297	CcSEcCtD
Nalidixic Acid—Arthralgia—Epirubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—sarcoma	0.00286	0.00286	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—sarcoma	0.00285	0.00285	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Epirubicin—sarcoma	0.0028	0.0028	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Epirubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—sarcoma	0.00271	0.00271	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—sarcoma	0.00259	0.00259	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Nalidixic Acid—Paraesthesia—Epirubicin—sarcoma	0.00252	0.00252	CcSEcCtD
Nalidixic Acid—Somnolence—Epirubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Nalidixic Acid—Paraesthesia—Doxorubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Epirubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Nalidixic Acid—Urticaria—Epirubicin—sarcoma	0.00223	0.00223	CcSEcCtD
Nalidixic Acid—Abdominal pain—Epirubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—sarcoma	0.00206	0.00206	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Nalidixic Acid—Asthenia—Epirubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Nalidixic Acid—Pruritus—Epirubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Nalidixic Acid—Diarrhoea—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Nalidixic Acid—Asthenia—Doxorubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Nalidixic Acid—Dizziness—Epirubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Nalidixic Acid—Vomiting—Epirubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Nalidixic Acid—Diarrhoea—Doxorubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Nalidixic Acid—Rash—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Nalidixic Acid—Dermatitis—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Nalidixic Acid—Headache—Epirubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Nalidixic Acid—Nausea—Epirubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Nalidixic Acid—Headache—Doxorubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Nalidixic Acid—Nausea—Doxorubicin—sarcoma	0.00154	0.00154	CcSEcCtD
